Constructive Bio

📍 Little Chesterford, United Kingdom🗓 Founded 2021👥 24 employees💰 Last funded May 2022
Biotechnology Research
LinkedIn
With the power to skillfully write meaningful DNA sequences, we embark on a new era where precise control over biology and the manipulation of matter in our environment is possible. Constructive Biology is a spin out from the laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology in Cambridge. Our platform allow us to fundamentally reprogram the genetic code, and make molecules that nature could not make before. We will use our technologies to biosynthesize new classes of enzymes, pharmaceuticals and biomaterials. If you would like to join our team, get in touch!
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Frequently asked questions
Who invested in Constructive Bio?
Constructive Bio has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Constructive Bio last raise funding?
The most recent investment in Constructive Bio recorded on gritt.io was in May 2022.
When was Constructive Bio founded?
Constructive Bio was founded in 2021.
What industry is Constructive Bio in?
Constructive Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Constructive Bio based?
Constructive Bio is headquartered in Little Chesterford, United Kingdom.